General - Press Releases

Date	Title	Company
03-Jan-2022	Trinseo Completes Acquisition of Heathland B.V.	Businesswire
03-Jan-2022	Amylyx Pharmaceuticals Announces Launch of Initial Public Offering	Businesswire
03-Jan-2022	4D pharma appoints John Doyle as Chief Financial Officer	Businesswire
03-Jan-2022	Lenzilumab Treatment Response in Hospitalized COVID-19 Patients Correlates with C-Reactive Protein Levels	Businesswire
28-Dec-2021	Enalare Therapeutics Invited to Present at Upcoming Biotech Conferences	Newswire
28-Dec-2021	Can British stoicism cause more harm than good? New study reveals that Brits have the highest resilience and sense of solidarity in Europe since the start of the COVID-19 pandemic, but many could be masking mental health issues and not asking for help	Merck
23-Dec-2021	MHRA approves licence extension for Novartis’ targeted therapy for advanced breast cancer patients in Great Britain	Novartis
22-Dec-2021	Qualer Has Added New Automation Software Features for Their Asset Maintenance Software Solutions	Newswire
21-Dec-2021	Research Partnership ranks 12th in fastest growing UK market research agency league tables	Research Partnership
20-Dec-2021	Advancing AI Drug Discovery in Clinical Trials at SMi’s 3rd Annual AI in Drug Discovery Conference	SMi Group
20-Dec-2021	Oral Splicing Modifiers that Systemically Lower Huntington Disease Protein Discovered Through PTC Therapeutics’ Innovative Splicing Platform	PTC Therapeutics
20-Dec-2021	SMi’s 10th Annual Pharmaceutical Microbiology UK Conference - A Virtual Conference with Online Access Only	SMi Group
16-Dec-2021	North-South MedTech Summit features healthcare and technology speakers across the UK	Empact Ventures
15-Dec-2021	Hyris Fully Embraces the Immunology Sector to Better Fight COVID-19 and Beyond, Presenting Its New, Disruptive T-Cell Test to the International Conference 'A-Wish'	Newswire
15-Dec-2021	The FDA Goes Live with LifeSphere MultiVigilance, Modernizing Pharmacovigilance Capabilities with FAERS II	ArisGlobal
14-Dec-2021	Scottish Medicines Consortium Accepts Imbruvica® (ibrutinib) for Adult Patients with Waldenström's macroglobulinaemia	Janssen
14-Dec-2021	Enalare Therapeutics Receives Rare Pediatric Disease Designation for Lead Compound ENA-001 for the Treatment of Apnea of Prematurity	Newswire
13-Dec-2021	Courier Health Named One of the Most Innovative Startups of 2021 by PM360	Newswire
13-Dec-2021	COP26 President Alok Sharma praises Tower Cold Chain for sustainable pharmaceutical logistics	Tower Cold Chain
11-Dec-2021	Bristol Myers Squibb’s Breyanzi (lisocabtagene maraleucel) Significantly Improves Outcomes, Showing Superiority Over 20-Year Standard of Care in Second-Line Relapsed or Refractory Large B-cell Lymphoma Based on TRANSFORM Study Results	Businesswire